Diversity Supplement to UC Davis CounterACT Center of Excellence: Role of IL-1β in mediating the chronic adverse neurological effects of acute organophosphate intoxication.
加州大学戴维斯分校 CounterACT 卓越中心的多样性补充:IL-1β 在介导急性有机磷中毒的慢性不良神经学影响中的作用。
基本信息
- 批准号:10837432
- 负责人:
- 金额:$ 1.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute DiseaseAdolescentAntiepileptogenicAutoimmune DiseasesBiological MarkersBrainChemicalsChronicChronic Phase of DiseaseClinicalClinical TrialsCognitiveCommunitiesConvulsantsDataDrug resistanceEnsureEpilepsyEpileptogenesisEtiologyEventExperimental ModelsFaceFemaleFeverGenerationsGoalsHumanIL1R1 geneImpaired cognitionIndividualInfectionInflammationInflammatoryInterleukin-1 betaIntoxicationIsoflurophateKnowledgeLifeMediatingMemory LossModelingMorbidity - disease rateNeurologicNeurologic DeficitNeurologic EffectOrganophosphatesOutcomePatientsPreparationRattusRecombinantsRecurrenceResearchResearch ActivityRoleSeizuresSignal TransductionSomanStatus EpilepticusSurvivorsSyndromeTBI PatientsTechnical ExpertiseTestingTherapeuticTrainingWorkanakinraantagonistcareercareer networkingchemical threatdisabilityeffective therapyexperienceimprovedlipid mediatormalemass casualtymedical countermeasurenerve agentneuroinflammationneuroprotectionparent grantskillsspatiotemporalstandard of caretherapeutic targettherapeutically effective
项目摘要
Abstract
Convulsant chemical threat agents, such as the organophosphates (OPs) diisopropylfluorophosphate (DFP) and
soman, can trigger seizures that progress to life-threatening status epilepticus (SE). Survivors face significant,
long-term morbidity, including spontaneous recurrent seizures (SRS) and mild-to-severe memory loss. Current
medical countermeasures fail to sufficiently protect against these long-term neurological deficits. The work
described in this Diversity supplement will use a well-established rat model of acute DFP intoxication to test the
hypothesis that administering therapies that antagonize interleukin-1β (IL-1β) signaling as adjuncts to standard
of care will mitigate the long-term, adverse neurological consequences of acute OP intoxication. The scientific
premise for this hypothesis includes clinical and experimental evidence that: (1) IL-1β levels are predictive of
epileptogenesis in patients with traumatic brain injury; (2) Anakinra, a commercially available recombinant human
IL-1R antagonist (IL1Ra) used to treat autoimmune disorders, is anti-epileptogenic in experimental models; (3)
In clinical trials, anakinra successfully reduced unremitting seizures in both the acute and chronic disease phases
of FIRES (Febrile Infection-Related Epilepsy Syndrome); and (4) Anakinra reduced drug-resistant seizures in
adolescents with epilepsy associated with an inflammatory etiology. The research goals of this Diversity
supplement are to: (1) Characterize the spatiotemporal profile of IL-1β signaling in the brain of male and female
rats following acute DFP intoxication in order to determine therapeutic windows, and develop translatable
biomarkers of inflammation that predict SRS and/or cognitive dysfunction and (2) Evaluate the neuroprotective
efficacy of anakinra in male and female rats acutely intoxicated with DFP. This research is complementary to
and extends the research described in the parent grant, which is focused on lipid mediators of neuroinflammation
as therapeutic targets. The training goals of this Diversity supplement include: (1) Develop the trainee’s
knowledge and technical skill set to enable them to successfully conduct research on medical countermeasures;
(2) Guide the trainee’s research activity to ensure the generation of data needed to support their preparation of
a competitive F31 application and advance to candidacy, was well as inform the feasibility of therapeutically
targeting IL-1β signaling to mitigate the long-term adverse neurological consequences of acute OP intoxication;
(3) Enhance the trainee’s professional skills; and (4) Actively work with the trainee to build their professional
networks to enhance their likelihood of transitioning to an independent career in academic research.
摘要
惊厥性化学威胁剂,如有机磷酸盐(OP)二异丙基氟磷酸盐(DFP)和
梭曼可引发癫痫发作,发展为危及生命的癫痫持续状态(SE)。幸存者面临着重大的,
长期发病率,包括自发性复发性癫痫发作(SRS)和轻度至重度记忆丧失。电流
医疗对策不能充分防止这些长期的神经缺陷。工作
本多样性补充中所述的方法将使用一种成熟的急性DFP中毒大鼠模型来测试
假设给予拮抗白细胞介素-1 β(IL-1β)信号传导的疗法作为对标准IL-1β抑制剂,
护理将减轻急性OP中毒的长期不良神经后果。科学
这一假设的前提包括临床和实验证据:(1)IL-1β水平预测
创伤性脑损伤患者的癫痫发生;(2)Anakinra,一种市售的重组人
IL-1 R拮抗剂(IL 1 Ra)用于治疗自身免疫性疾病,在实验模型中具有抗癫痫作用;(3)
在临床试验中,阿那白滞素成功地减少了急性和慢性疾病阶段的持续癫痫发作
的FIRES(发热性惊厥相关癫痫综合征);和(4)阿那白滞素减少耐药性癫痫发作,
与炎性病因相关的青少年癫痫。多样性的研究目标
补充如下:(1)描述了IL-1β信号在男性和女性脑中的时空分布
大鼠急性DFP中毒,以确定治疗窗口,并制定翻译
预测SRS和/或认知功能障碍的炎症生物标志物,和(2)评估神经保护性
阿那白滞素对DFP急性中毒雌雄大鼠疗效观察这项研究是对
并扩展了父母资助中描述的研究,该研究集中在神经炎症的脂质介质上
作为治疗靶点。本多元化补充材料的培训目标包括:(1)培养学员的
使他们能够成功地进行医疗对策研究的知识和技术技能;
(2)指导受训者的研究活动,以确保生成支持其准备工作所需的数据。
一个有竞争力的F31申请和候选资格的进展,以及告知治疗的可行性,
靶向IL-1β信号传导以减轻急性OP中毒的长期不良神经学后果;
(3)提高受训者的专业技能;及(4)积极与受训者合作,
网络,以提高他们过渡到学术研究的独立职业生涯的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amy R. Brooks-Kayal其他文献
Amy R. Brooks-Kayal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amy R. Brooks-Kayal', 18)}}的其他基金
Diversity Supplement to UC Davis CounterACT Center of Excellence: The role of the JAK/STAT signaling pathway in chronic neurological effects of acute organophosphate intoxication
加州大学戴维斯分校 CounterACT 卓越中心的多样性补充:JAK/STAT 信号通路在急性有机磷中毒的慢性神经系统影响中的作用
- 批准号:
10834649 - 财政年份:2023
- 资助金额:
$ 1.48万 - 项目类别:
The STAT3 response of excitatory neurons to epileptogenic brain injury
兴奋性神经元对致癫痫性脑损伤的 STAT3 反应
- 批准号:
10467510 - 财政年份:2022
- 资助金额:
$ 1.48万 - 项目类别:
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
加州大学戴维斯分校 CounterACT 卓越中心:制定缓解急性有机磷中毒慢性神经系统后果的治疗策略
- 批准号:
10852174 - 财政年份:2022
- 资助金额:
$ 1.48万 - 项目类别:
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
加州大学戴维斯分校 CounterACT 卓越中心:制定缓解急性有机磷中毒慢性神经系统后果的治疗策略
- 批准号:
10684066 - 财政年份:2022
- 资助金额:
$ 1.48万 - 项目类别:
UC Davis CounterACT Center of Excellence: Developing Therapeutic Strategies for Mitigating the Chronic Neurological Consequences of Acute Organophosphate Intoxication
加州大学戴维斯分校 CounterACT 卓越中心:制定缓解急性有机磷中毒慢性神经系统后果的治疗策略
- 批准号:
10852175 - 财政年份:2022
- 资助金额:
$ 1.48万 - 项目类别:
The STAT3 Response of Excitatory Neurons to Epileptogenic Brain Injury
兴奋性神经元对癫痫性脑损伤的 STAT3 反应
- 批准号:
10610469 - 财政年份:2022
- 资助金额:
$ 1.48万 - 项目类别:
The STAT3 response of excitatory neurons to epileptogenic brain injury
兴奋性神经元对致癫痫性脑损伤的 STAT3 反应
- 批准号:
10119388 - 财政年份:2020
- 资助金额:
$ 1.48万 - 项目类别:
Development of novel JAK/STAT inhibitors for Epilepsy prevention and treatment
开发用于癫痫预防和治疗的新型 JAK/STAT 抑制剂
- 批准号:
8659954 - 财政年份:2014
- 资助金额:
$ 1.48万 - 项目类别:
GABA (A) Receptor Subunit Regulation in Epileptogenesis
GABA (A) 受体亚基在癫痫发生中的调节
- 批准号:
7730222 - 财政年份:2006
- 资助金额:
$ 1.48万 - 项目类别:
GABA (A) Receptor Subunit Regulation in Epileptogenesis
GABA (A) 受体亚基在癫痫发生中的调节
- 批准号:
7032192 - 财政年份:2006
- 资助金额:
$ 1.48万 - 项目类别:
相似海外基金
Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
- 批准号:
10712647 - 财政年份:2001
- 资助金额:
$ 1.48万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
6247642 - 财政年份:1997
- 资助金额:
$ 1.48万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
3718999 - 财政年份:
- 资助金额:
$ 1.48万 - 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
- 批准号:
465668867 - 财政年份:
- 资助金额:
$ 1.48万 - 项目类别:
Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
- 批准号:
3719026 - 财政年份:
- 资助金额:
$ 1.48万 - 项目类别: